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Introduction
In most species, the hepatic metabolism of 
glucose includes the synthesis of ascorbic acid (1). In 
man, monkey and guinea pigs, however, the absence 
of one enzyme in that pathwey (2) necessitates the 
dietary intake of a micronutrient. Term „antiscorbutic 
chemical“ in citrus fruits was well appreciated long 
before Szent-Georgi’s (3) isolation of ascorbic acid 
itself in 1928.
In particular, the cellular uptake of ascorbic 
acid is regulated by both glucose and insulin and 
the renal reabsorption of ascorbic acid is impeared 
by hyperglycemia (4). This evidence also suggests 
that vitamin C supplementation may be beneficial in 
countering the pathophysiologies resulting from the 
chronic hyperglycemia of insulin-dipendent diabetes 
mellitus (IDDM).
Levels of ascorbic acid are decreased in various 
tissues of animals with experimental diabetes (5). 
Mann suggested (6) in 1974 that glucose and vitamin 
C might occupy the same membrane transport system. 
He subsequently reported with Newton (7) that 
elevated glucose levels interfered with cellular ascorbic 
acid transport in erythrocytes. Others have observed 
inhibition by glucose of ascorbic acid in vitro by 
human lymphocytes (8) and  bovine endothelial cells 
(9). Bigley et al. (10) described competitive inhibition 
between the in vitro uptake of dehydroascorbic acid 
and glucose analogues by human polymorphonuclear 
leucocytes (PMN) and fibroblasts, and concluded on 
the basis of kinetic data that the competing ligands 
utilized the same membrane carrier.
In this study we compared the effects of ascorbic 
acid on the glucose levels in the plasma. 
Materials and methods
During 2002. the level of glycemia and ascorbic 
acid was tested at Gynecology clinic in Nis. This 
test was done on thirty healthy normoglycemic adult 
women, aged between 18 and 30, who had no clinical 
signs of endocrine disturbances. 
At the beginning of the experiment the level of 
ascorbic acid and the level of glycemia were determined 
twelve hours after the last meal. In the following seven 
days each of the examined women was given, beside 
the usual nourishment, 1.000 mg ascorbic acid (two 
times a day of 500 mg with breakfast and lunch). The 
level of ascorbic acid and glycemia was determined on 
the eight day of the experiment, tventy-four hours after 
the last taken dosage of ascorbic acid. The achieved 
results of oral glucose-tolerance test (OGTT) at the 
beginning and in the end of the test were shown in a 
table and on diagram.
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The level of glycemia and ascorbic acid was tested of oral glucose-tolerance test (OGTT). 
This test was done on thirty healthy normoglycemic adult women, between 18 and 30 years of 
age, who showed no clinical signs of endocrine disturbances. 
At the beginning of the experiment the level of ascorbic acid and the level of glycemia 
were determined twelve hours after the last meal. In the following seven days eash of the 
examined women was given, beside the usual nourishment, 1.000 mg ascorbic acid (two times 
a day of 500 mg with breakfast and lunch). The level of ascorbic acid the last taken dosage 
of ascorbic acid. The achieved results  of OGTT at the beginning and in the end of the test 
showed the ascorbic acid in the dosage of 1.000 mg/per day for seven days intensified the level 
glycemia during OGTT.
This hyperglycemy is probably the consequence of the receptor obstruction in cellular 
membrane by ascorbic acid. Acta Medica Medianae 2004; 43 (1):39‡41.
Key words: level of glycemia, ascorbic acid, oral glucose - tolerance test
www.medfak.ni.ac.yu/amm40
The effects of ascorbic acid on membrane transport of glucose  Voja Pavlovic and Zoran Pavlovic
The results
In the case of thirty normoglycemic adult women, 
aged between 18 and 30, the oral glucose tolerance test 
was done with 75 g of glucose. The achieved values of 
glycemia were shown in table 1.
Table 1. The values of glycemia during OGTT (mmol/L) at 
the beginning of the experiment
Time (min) 0 30 60 90 120
glucochemy 3,77 6,82 7,93 7,04 4,1
After OGTT was done, and after taking 1.000 mg 
of ascorbic acid every day, the oral glucose-tolerance 
test was determined. The achieved values were given 
in table 2. 
Table 2. The values of glycemia during OGTT (mmol/L) in 
the end of the experiment
Time (min) 0 30 60 90 120
glucochemy 4,16 9,1 10,71 9,04 6,82
The above given results show the existence 
of the level of glycemia in the case of all examined 
normoglycemic adult women, after taking 1 g of 
ascorbic acid during the period of seven days. This 
difference is more obvious on the following diagram 
(diagram 1).
Namely, the level of glycemia, after applying 
ascorbic acid is higher in all the intervals of 
determining of oral glucose tolerance test (OGTT). 
These differences are more important statistically (p 
< 0,001).
Discussion
In most species, the hepatic metabolism of 
glucose includes the synthesis of ascorbic acid. 
Glucose has a similar structure, and is the precursor 
for the vitamin in species that synthesize it (11). 
Although the biosynthetic relationship between 
glucose and vitamin C is absent in man, on the basis 
of in vitro examination of tissue homogenate extracts 
Burns (2) concluded that, man, monkey and guinea 
pig were unable to convert L-gulonolactone to l-
ascorbic acid, and that this was the „missing step“ in 
the biosynthesis in the livers of these species which 
made them dependent on exogenous ascorbic acid for 
their vitamin C requirements. Chatterjee et al. (12) 
concluded that there existed an additional „missing 
step“, namely that performed in other species by the 
enzyme L-glucuronolacton oxdidase in converting 
D-glucuronolactone to L-gulonolactone. More spe-
cifically Burns (2), Stone (13) and Chatterjee et al. 
(12) considered that the „missing step“ was due to 
gene deletion. 
In his seminar paper „Evolution and the Need for 
Ascorbic Acid“ Linus Pauling (14) concluded that the 
loss of the ability to synthesize ascorbic acid probably 
occurred in the common ancestor of the primates. 
A rought estimate of the time when this mutational 
change occurred is twenty-five million years ago. 
Weighty experimental and theoretical consi-
derations will advise in favour of the thesis that vitamin 
C deficiency in a number of species including humans 
is not due to rotal inability to biosynthesis ascorbate, 
but rather to a very limited biosynthetic ability which 
normally cannot be stopped to meet the minimum 
metabolic/physiological requirements (15,16,17,18).
The cellular uptale of ascorbic acid from plasma 
can occur by two mechanisms. An active transport of 
ascorbic acid is documented (4,19). With regard to this 
active transport, insulin has been proved to accelerate 
ascorbic acid clearanse from plasma, and presumably 
into cells since there is no increase in urinary excretion 
(20, 21). 
Hyperglycemia has been shown to inhibit 
ascorbic acid transport. This inhibition seems to para- 
doxically give the evidence suggesting that insulin 
promotes both ascorbic acid and dehydroascorbic acid 
(DHA) uptake by cells. The inhibition of ascorbic acid 
uptake by hyperglycemia was demonstrated in vitro 
in the absence of insulin and may not, therefore, be 
important in normal physiology. Hyperglycemia is 
also known to enhance renal ascorbic acid lowes (4, 
20,23).
The glucose transport system also transports 
the minor oxidized and uncharged species, DHA 
with a presumed subsequent intracellular reduction 
to ascorbic acid. Cunningham (24) showed that DHA 
competed for glucose transport system transported on 
an equimolar basis with the transport surrogates 2-
deohy-glucose and 3-O-methyl glucose. Earlier studies 
(10) clearly show an enhancement of leucocyte DHA 
uptake by insulin, consistent with the requirement of 
glucose transport system transporters from the cytosol 
to membrane surfaces. Much emphasis has been placed 
on this potential uptake mechanism (24). 
Conclusion
The results of this experiments autorized us to 
conclude:
Taking of the ascorbic acid in the dosage of 
1.000 mg/per day for seven days, intensifies the level   
of glycemia druging OGGT.
This hyperglycemy is probably the consequence 
of the receptor obstruction in cellular membrane by 
ascorbic acid. 
Diagram 1. The values of glycemia during OGTT (mmol/L) 
at he beginning and at the end of the experiment41
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UTICAJ PERORALNOG UNOSA
ASKORBINSKE KISELINE
NA NIVO GLIKEMIJE KOD ZDRAVIH OSOBA
Voja Pavlovi} i Zoran Pavlovi}
U medicinskoj literaturi postoje mnogobrojni podaci o efektima askorbinske kiseline na 
pojedine aktivnosti organizma. Me|utim, relativno mali broj radova obra|uje problem efekata 
askorbinske kiseline na nivo glikemije i sistem glikoregulacije.
Izu~avan je uticaj askorbinske kiseline na nivo glikemije kod 30 zdravih, 
normoglikemi~nih `ena, starosti izme|u 18 i 30 godina, koje nisu imale klini~ke simptome 
nekog endokrinog poreme}aja. Kod svih ispitanica ura|en je oralni glikozo-tolerans test 
(OGTT) sa 75 g glikoze, na po~etku ogleda. Narednih sedam dana, svaka ispitanica, per os, 
unosila je po 1.000 mg askorbinske kiseline na dan. Osmog dana (24 h posle poslednje doze 
unete askorbinske kiseline), kod svake ispitanice, ura|en je OGTT. Dobijeni rezultati pokazuju 
da postoji zna~ajna razlika u nivou glikemije, pre i posle uzimanja askorbinske kiseline. Posle 
sedmodnevnog uzimanja askorbinske kiseline nivo glikemije je zna~ajno vi{i, du`e traje i 
sporije se vra}a na po~etnu vrednost. Ova razlika u nivou glikemije, mogla bi biti posledica 
kopetitivnog delovanja askorbinske kiseline i glikoze na zajedni~ke receptore transportnog 
mehanizma u celularnim membranama. Acta Medica Medianae 2004; 43 (1):39 ‡ 41.
Klju~ne re~i: askorbinska kiselina, glikemija, oralni glikozo-tolerans test